Low-dose methotrexate administered weekly is an effective corticosteroid-sparing agent for the treatment of the cutaneous manifestations of dermatomyositis-Reference-Cited by-同舟云学术

Low-dose methotrexate administered weekly is an effective corticosteroid-sparing agent for the treatment of the cutaneous manifestations of dermatomyositis

Published:1997-01 Issue:1 Volume:36 Page:67-71
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Kasteler J.Scott,Callen Jeffrey P.

Publisher

Elsevier BV

Subject

Dermatology

Reference22 articles.

1. Dermatomyositis and polymyositis;Callen;Dis Mon,1987

2. Dermatomyositis with normal muscle enzyme concentrations;Stonecipher;Arch Dermatol,1994

3. Immunosuppressive and cytotoxic drugs: uses in the dermatologic patient;Callen;Adv Dermatol,1990

4. Adult-onset polymyositis-dermatomyositis: description of 25 patients with emphasis on treatment;Ramirez;Semin Arthritis Rheum,1990

5. Current treatment of the inflammatory myopathies;Dalakas;Curr Opin Rheumatol,1994

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updates in Dermatomyositis: Newer Treatment Options and Outcome Measures From Dermatologic Perspectives;Annals of Dermatology;2024

2. Dermatomyositis: a comprehensive review of clinical manifestations, serological features, and therapeutic approaches;Italian Journal of Dermatology and Venereology;2023-05

3. Combination Therapy for Psoriasis with Methotrexate and Other Oral Disease-Modifying Antirheumatic Drugs: A Systematic Review;Dermatology and Therapy;2023-03-21

4. Diagnosis and Management of Cutaneous Manifestations of Autoimmune Connective Tissue Diseases;Clinical, Cosmetic and Investigational Dermatology;2022-10

5. Past, Present, and Future in Dermatomyositis Therapeutics;Current Treatment Options in Rheumatology;2022-07-26